Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Allergy and Asthma Proceedings
|
December 10, 2016
Idiopathic CD4 lymphocytopenia
Joel P Brooks, Gisoo Ghaffari
Allergy and Asthma Proceedings
|
February 3, 2016
A 73-year-old woman with persistent diarrhea and onychomycosis
Larisa Buyantseva, Joel P Brooks, Timothy Craig
The Journal of Allergy and Clinical Immunology. in Practice
|
May 20, 2020
The Future of Telehealth in Allergy and Immunology Training
Anjeni Keswani, Joel P Brooks, Paneez Khoury
Allergy and Asthma Proceedings
|
October 28, 2020
Clinical presentation of hereditary angioedema
Veronica Azmy, Joel P Brooks, F Ida Hsu
Allergy and Asthma Proceedings
|
August 29, 2023
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)
Stella Hartono, Elena Zidan, Prasiksha Sitaula, et al.
Allergy and Asthma Proceedings
|
July 25, 2020
A 79-year-old man with persistent eosinophilia and elevated immunoglobulin E
Joel P Brooks, Kaoru Harada, Nicole K Le, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 27, 2025
Controversies in Allergy: Does Using Epinephrine Always Mean Calling 911?
Lydia Su Yin Wong, Erik Anderson, Joel P Brooks, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 7, 2020
Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review
Joel P Brooks, Cristine Radojicic, Marc A Riedl, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 20, 2019
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity
Joel P Brooks, Veronica Azmy, Alison Thompson, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
February 12, 2020
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
Donald S Levy, Henriette Farkas, Marc A Riedl, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Allergy and Asthma Proceedings
|
December 10, 2016
Idiopathic CD4 lymphocytopenia
Joel P Brooks, Gisoo Ghaffari
Allergy and Asthma Proceedings
|
February 3, 2016
A 73-year-old woman with persistent diarrhea and onychomycosis
Larisa Buyantseva, Joel P Brooks, Timothy Craig
The Journal of Allergy and Clinical Immunology. in Practice
|
May 20, 2020
The Future of Telehealth in Allergy and Immunology Training
Anjeni Keswani, Joel P Brooks, Paneez Khoury
Allergy and Asthma Proceedings
|
October 28, 2020
Clinical presentation of hereditary angioedema
Veronica Azmy, Joel P Brooks, F Ida Hsu
Allergy and Asthma Proceedings
|
August 29, 2023
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)
Stella Hartono, Elena Zidan, Prasiksha Sitaula, et al.
Allergy and Asthma Proceedings
|
July 25, 2020
A 79-year-old man with persistent eosinophilia and elevated immunoglobulin E
Joel P Brooks, Kaoru Harada, Nicole K Le, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 27, 2025
Controversies in Allergy: Does Using Epinephrine Always Mean Calling 911?
Lydia Su Yin Wong, Erik Anderson, Joel P Brooks, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 7, 2020
Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review
Joel P Brooks, Cristine Radojicic, Marc A Riedl, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 20, 2019
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity
Joel P Brooks, Veronica Azmy, Alison Thompson, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
February 12, 2020
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
Donald S Levy, Henriette Farkas, Marc A Riedl, et al.
Page
of 2